Ipilimumab vs Tazobactam Sodium
Ipilimumab vs Tazobactam Sodium: Overview
This comparison examines the pharmacological differences between Ipilimumab and Tazobactam Sodium.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Tazobactam Sodium — Small molecule.